Clinical Trials
5 trialsNCT07390565 2026-02-09
YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Enrolling by invitation
NCT06419179 2025-05-20
GUIDANCE
University of Cologne
Phase 2 Enrolling by invitation
NCT06816966 2025-02-10
CISART
Fujian Medical University Union Hospital
Phase 2 Enrolling by invitation
NCT06773156 2025-01-14
Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer
Second Affiliated Hospital of Nanchang University
Phase 2 Enrolling by invitation
NCT06747832 2024-12-24
iNK-SCLC
Guangzhou Ruixin Biotechnological Co., LTD
Phase EARLY_PHASE1 Enrolling by invitation